Drug reference
diethylcarbamazine citrate
Anthelmintic, Microfilaricidal
Anthelmintic, Microfilaricidal
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Primarily microfilaricidal, it has a highly selective effect on microfilariae by altering their organelle membranes, promoting cell death. It may also affect the muscular activity of microfilariae and adult worms, causing their dislodgement. Prolonged treatment may kill adult Brugia malayi and Wuchereria bancrofti worms, making it a slow-acting macrofilaricidal agent.
Indications
Filariasis (Wuchereria bancrofti, Brugia malayi)Tropical pulmonary eosinophiliaLoa loa infectionOnchocerca volvulus infection (with caution, ivermectin preferred)
Dosing
- Adult
- Filariasis: 2 mg/kg TDS (for 7 days). For radical cure, total dose of 72–126 mg/kg spread over 12 days to 3 weeks. Mass treatment: 6 mg/kg single dose annually (with albendazole 400 mg). Tropical pulmonary eosinophilia: 2–4 mg/kg TDS for 2–3 weeks. Loa loa and O. volvulus: small (25–50 mg) test dose initially.
- Pediatric
- Same as adult dosing for filariasis.
Pharmacokinetics
Half-life
4–12 hours (plasma, depending on urinary pH)
Metabolism
Metabolized in liver.
Excretion
Excreted in urine (faster in acidic urine).
Side effects
Common
NauseaLoss of appetiteHeadacheWeaknessDizziness
Serious
- Febrile reaction with rash
- Pruritus
- Enlargement of lymph nodes
- Bronchospasm
- Fall in BP (due to mass destruction of Mf and adult worms)
- Leukocytosis
- Mild albuminuria
Pregnancy & lactation
Lactation
Excretion is faster in acidic urine.
Related guidelines
Other Unclassified drugs
Ask House about diethylcarbamazine citrate
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: KD Tripathi 7e·Verified: 2026-05-10 · House clinical team